{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:40:59Z","timestamp":1777290059598,"version":"3.51.4"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000658","name":"Myotubular Trust","doi-asserted-by":"publisher","award":["KCL01"],"award-info":[{"award-number":["KCL01"]}],"id":[{"id":"10.13039\/501100000658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.spen.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T07:47:32Z","timestamp":1547624852000},"page":"71-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Therapeutic Aspects in Congenital Myopathies"],"prefix":"10.1016","volume":"29","author":[{"given":"Heinz","family":"Jungbluth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.spen.2019.01.004_bib0001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","article-title":"The congenital myopathies \u2013 Inherited disorders of excitation-contraction coupling and muscle contraction","volume":"14","author":"Jungbluth","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0002","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0883073812436605","article-title":"Consensus statement on standard of care for congenital myopathies","volume":"27","author":"Wang","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0003","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semcdb.2016.08.004","article-title":"Current and future therapeutic approaches to the congenital myopathies","volume":"64","author":"Jungbluth","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.spen.2019.01.004_bib0004","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.spen.2011.10.005","article-title":"Core myopathies","volume":"18","author":"Jungbluth","year":"2011","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2013.01.004","article-title":"Congenital myopathies\u2013Clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom","volume":"23","author":"Maggi","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2019.01.004_bib0006","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng0993-46","article-title":"A mutation in the human ryanodine receptor gene associated with central core disease","volume":"5","author":"Zhang","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0007","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/01.wnl.0000188870.37076.f2","article-title":"Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene","volume":"65","author":"Jungbluth","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2019.01.004_bib0008","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/342719","article-title":"Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: Reassessing the nosology of early-onset myopathies","volume":"71","author":"Ferreiro","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0009","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.nmd.2012.06.007","article-title":"Mutations in MYH7 cause multi-minicore disease (MmD) with variable cardiac involvement","volume":"22","author":"Cullup","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2019.01.004_bib0010","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/hmg\/ddt494","article-title":"Recessive TTN truncating mutations define novel forms of core myopathy with heart disease","volume":"23","author":"Chauveau","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.spen.2019.01.004_bib0011","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archneurol.2011.188","article-title":"Muscle MRI in congenital myopathies due to Ryanodine receptor type 1 (RYR1) gene mutations","volume":"68","author":"Klein","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2010.01.014","article-title":"Centronuclear myopathies: A widening concept","volume":"20","author":"Romero","year":"2010","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.spen.2019.01.004_bib0013","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng0696-175","article-title":"A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast","volume":"13","author":"Laporte","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0014","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ng1657","article-title":"Mutations in dynamin 2 cause dominant centronuclear myopathy","volume":"37","author":"Bitoun","year":"2005","journal-title":"Nat Genet"},{"issue":"Pt 12","key":"10.1016\/j.spen.2019.01.004_bib0015","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/brain\/awu272","article-title":"Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations","volume":"137","author":"Bohm","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.spen.2019.01.004_bib0016","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.22119","article-title":"RYR1 mutations are a common cause of congenital myopathies with central nuclei","volume":"68","author":"Wilmshurst","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0017","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng2086","article-title":"Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy","volume":"39","author":"Nicot","year":"2007","journal-title":"Nat Genet"},{"issue":"14","key":"10.1016\/j.spen.2019.01.004_bib0018","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/WNL.0b013e3182a6ca62","article-title":"Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy","volume":"81","author":"Ceyhan-Birsoy","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2019.01.004_bib0019","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(99)70417-8","article-title":"Medical complications in long-term survivors with X-linked myotubular myopathy","volume":"134","author":"Herman","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.spen.2019.01.004_bib0020","series-title":"Muscle Biopsy: A Practical Approach","author":"Dubowitz","year":"2013"},{"key":"10.1016\/j.spen.2019.01.004_bib0021","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1073\/pnas.96.5.2305","article-title":"Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy","volume":"96","author":"Pelin","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.spen.2019.01.004_bib0022","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.1080","article-title":"Nemaline myopathy: A clinical study of 143 cases","volume":"50","author":"Ryan","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0023","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/13837","article-title":"Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy","volume":"23","author":"Nowak","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0024","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng0195-75","article-title":"A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy","volume":"9","author":"Laing","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0960-8966(01)00252-8","article-title":"Mutations in the beta-tropomyosin (TPM2) gene\u2013A rare cause of nemaline myopathy","volume":"12","author":"Donner","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2019.01.004_bib0026","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ajhg.2010.10.020","article-title":"Dominant mutations in KBTBD13, a member of the BTB\/Kelch family, cause nemaline myopathy with cores","volume":"87","author":"Sambuughin","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0027","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1086\/303089","article-title":"A novel nemaline myopathy in the Amish caused by a mutation in troponin T1","volume":"67","author":"Johnston","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0028","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/510402","article-title":"Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2","volume":"80","author":"Agrawal","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0029","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajhg.2016.11.017","article-title":"Biallelic Mutations in MYPN, encoding myopalladin, are associated with childhood-onset, slowly progressive nemaline myopathy","volume":"100","author":"Miyatake","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajhg.2013.05.004","article-title":"Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy","volume":"93","author":"Ravenscroft","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0031","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2013.10.020","article-title":"Identification of KLHL41 mutations implicates BTB-Kelch-mediated ubiquitination as an alternate pathway to myofibrillar disruption in nemaline myopathy","volume":"93","author":"Gupta","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0032","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1172\/JCI75199","article-title":"Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy","volume":"124","author":"Yuen","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.spen.2019.01.004_bib0033","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/brain\/aws344","article-title":"Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies","volume":"136","author":"Davidson","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.spen.2019.01.004_bib0034","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.nmd.2004.08.005","article-title":"Magnetic resonance imaging of muscle in nemaline myopathy","volume":"14","author":"Jungbluth","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2019.01.004_bib0035","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/hmg\/3.8.1415","article-title":"A calcium channel mutation causing hypokalemic periodic paralysis","volume":"3","author":"Jurkat-Rott","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0036","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","article-title":"Presence of two different genetic traits in malignant hyperthermia families: Implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility","volume":"97","author":"Monnier","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.spen.2019.01.004_bib0037","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-016-1656-8","article-title":"Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy","volume":"133","author":"Schartner","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.spen.2019.01.004_bib0038","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12938","article-title":"Diseases caused by mutations in ORAI1 and STIM1","volume":"1356","author":"Lacruz","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.spen.2019.01.004_bib0039","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ajhg.2016.09.005","article-title":"Variants in the oxidoreductase PYROXD1 cause early-onset myopathy with internalized nuclei and myofibrillar disorganization","volume":"99","author":"O'Grady","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00401-012-1024-2","article-title":"Myosinopathies: Pathology and mechanisms","volume":"125","author":"Tajsharghi","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.spen.2019.01.004_bib0041","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/hmg\/dds514","article-title":"The neuronal endopeptidase ECEL1 is associated with a distinct form of recessive distal arthrogryposis","volume":"22","author":"Dieterich","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0042","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajhg.2012.11.014","article-title":"Mutations in ECEL1 cause distal arthrogryposis type 5D","volume":"92","author":"McMillin","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0043","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1073\/pnas.1221400110","article-title":"Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of distal arthrogryposis","volume":"110","author":"Coste","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.spen.2019.01.004_bib0044","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/brain\/awv352","article-title":"Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy","volume":"139","author":"Zaharieva","year":"2016","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2019.01.004_bib0046","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.nmd.2015.04.007","article-title":"Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy","volume":"25","author":"Kraeva","year":"2015","journal-title":"Neuromusc Disord"},{"issue":"6","key":"10.1016\/j.spen.2019.01.004_bib0047","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.nmd.2011.03.006","article-title":"King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"21","author":"Dowling","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2019.01.004_bib0048","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s00415-012-6817-7","article-title":"A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"260","author":"Loseth","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0049","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/ncomms2952","article-title":"Stac3 is a component of the excitation-contraction coupling machinery and mutated in native American myopathy","volume":"4","author":"Horstick","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.spen.2019.01.004_bib0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.coph.2008.01.005","article-title":"Congenital muscle disorders with cores: The ryanodine receptor calcium channel paradigm","volume":"8","author":"Treves","year":"2008","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"10.1016\/j.spen.2019.01.004_bib0051","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bbamcr.2010.11.009","article-title":"Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum","volume":"1813","author":"Maclennan","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.spen.2019.01.004_bib0052","doi-asserted-by":"crossref","first-page":"E9520","DOI":"10.1073\/pnas.1708852114","article-title":"Structural insights into binding of STAC proteins to voltage-gated calcium channels","volume":"114","author":"Wong King Yuen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.spen.2019.01.004_bib0053","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1073\/pnas.0806015105","article-title":"Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle","volume":"105","author":"Jurynec","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.spen.2019.01.004_bib0054","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.21644","article-title":"Oxidative stress in SEPN1-related myopathy: From pathophysiology to treatment","volume":"65","author":"Arbogast","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0055","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/brain\/awr004","article-title":"Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies","volume":"134","author":"Ravenscroft","year":"2011","journal-title":"Brain"},{"issue":"45","key":"10.1016\/j.spen.2019.01.004_bib0056","first-page":"E9520","article-title":"Disrupted myosin cross-bridge cycling kinetics triggers muscle weakness in nebulin-related myopathy","volume":"114","author":"Ochala","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spen.2019.01.004_bib0057","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/ana.24535","article-title":"TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype","volume":"78","author":"Donkervoort","year":"2015","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.spen.2019.01.004_bib0058","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ana.24654","article-title":"Mutation-specific effects on thin filament length in thin filament myopathy","volume":"79","author":"de Winter","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0059","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/ng.995","article-title":"Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD)","volume":"43","author":"Logan","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/hmg\/ddq515","article-title":"Satellite cell loss and impaired muscle regeneration in selenoprotein N deficiency","volume":"20","author":"Castets","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0061","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-213X-9-46","article-title":"Selenoprotein N is dynamically expressed during mouse development and detected early in muscle precursors","volume":"9","author":"Castets","year":"2009","journal-title":"BMC Dev Biol"},{"key":"10.1016\/j.spen.2019.01.004_bib0062","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/hmg\/ddn112","article-title":"AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis","volume":"17","author":"Buj-Bello","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0063","doi-asserted-by":"crossref","first-page":"14697","DOI":"10.1073\/pnas.1003677107","article-title":"MTM1 mutation associated with X-linked myotubular myopathy in labrador retrievers","volume":"107","author":"Beggs","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.spen.2019.01.004_bib0064","doi-asserted-by":"crossref","first-page":"220ra210","DOI":"10.1126\/scitranslmed.3007523","article-title":"Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy","volume":"6","author":"Childers","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.spen.2019.01.004_bib0065","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMcibr1403629","article-title":"Translating the genomic revolution-targeted genome editing in primates","volume":"370","author":"Cathomen","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2019.01.004_bib0066","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/hmg\/ddg121","article-title":"A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia","volume":"12","author":"Monnier","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0067","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/hum.2013.052","article-title":"Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathy","volume":"24","author":"Rendu","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.spen.2019.01.004_bib0068","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","article-title":"Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"McDonald","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2019.01.004_bib0069","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tig.2012.05.001","article-title":"The uncertain road towards genomic medicine","volume":"28","author":"MacArthur","year":"2012","journal-title":"Trends Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fnagi.2014.00339","article-title":"Pathogenic mechanisms in centronuclear myopathies","volume":"6","author":"Jungbluth","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.spen.2019.01.004_bib0071","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI71206","article-title":"Reducing dynamin 2 expression rescues X-linked centronuclear myopathy","volume":"124","author":"Cowling","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.spen.2019.01.004_bib0072","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1172\/JCI86841","article-title":"PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models","volume":"126","author":"Sabha","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.spen.2019.01.004_bib0073","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1083\/jcb.200812132","article-title":"Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin","volume":"185","author":"Nowak","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.spen.2019.01.004_bib0074","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1093\/hmg\/ddt252","article-title":"Cardiac alpha-actin over-expression therapy in dominant ACTA1 disease","volume":"22","author":"Ravenscroft","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0075","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/hmg\/ddt003","article-title":"Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy","volume":"22","author":"Lawlor","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0076","doi-asserted-by":"crossref","first-page":"26965","DOI":"10.1074\/jbc.272.43.26965","article-title":"Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors","volume":"272","author":"Fruen","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.spen.2019.01.004_bib0077","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1213\/00000539-199804000-00047","article-title":"Prophylactic use of dantrolene in a patient with central core disease","volume":"86","author":"Michalek-Sauberer","year":"1998","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.spen.2019.01.004_bib0078","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2011.12.003","article-title":"182nd ENMC International Workshop: RYR1-related myopathies, 15-17th April 2011, Naarden, the Netherlands","volume":"22","author":"Jungbluth","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2019.01.004_bib0079","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","article-title":"Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2019.01.004_bib0080","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/ALN.0000000000000732","article-title":"Malignant hyperthermia testing in probands without adverse anesthetic reaction","volume":"123","author":"Timmins","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.spen.2019.01.004_bib0081","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1111\/ene.13051","article-title":"Dantrolene as a possible prophylactic treatment for RYR1-related rhabdomyolysis","volume":"23","author":"Scalco","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0082","doi-asserted-by":"crossref","first-page":"ra68","DOI":"10.1126\/scisignal.aad9813","article-title":"An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities","volume":"9","author":"Lopez","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.spen.2019.01.004_bib0083","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI62834","article-title":"Calcium cycling proteins and heart failure: Mechanisms and therapeutics","volume":"123","author":"Marks","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.spen.2019.01.004_bib0084","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.ddmec.2010.09.009","article-title":"Fixing ryanodine receptor Ca leak\u2013A novel therapeutic strategy for contractile failure in heart and skeletal muscle","volume":"7","author":"Andersson","year":"2010","journal-title":"Drug Discov Today Dis Mech"},{"key":"10.1016\/j.spen.2019.01.004_bib0085","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2337\/diabetes.54.4.928","article-title":"Long-term AICAR administration and exercise prevents diabetes in ZDF rats","volume":"54","author":"Pold","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.spen.2019.01.004_bib0086","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cell.2008.02.042","article-title":"RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice","volume":"133","author":"Durham","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.spen.2019.01.004_bib0087","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nm.2598","article-title":"AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation","volume":"18","author":"Lanner","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.spen.2019.01.004_bib0088","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/jmedgenet-2012-101470","article-title":"Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutations","volume":"50","author":"de Winter","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2019.01.004_bib0089","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13395-015-0037-7","article-title":"Effect of levosimendan on the contractility of muscle fibers from nemaline myopathy patients with mutations in the nebulin gene","volume":"5","author":"de Winter","year":"2015","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.spen.2019.01.004_bib0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.2618","article-title":"Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases","volume":"18","author":"Russell","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.spen.2019.01.004_bib0091","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.1200113","article-title":"Cardiac myosin activation: A potential therapeutic approach for systolic heart failure","volume":"331","author":"Malik","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.spen.2019.01.004_bib0092","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/aws036","article-title":"Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy","volume":"135","author":"Dowling","year":"2012","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0093","doi-asserted-by":"crossref","first-page":"34514","DOI":"10.1074\/jbc.M404290200","article-title":"Identification of hyperreactive cysteines within ryanodine receptor type 1 by mass spectrometry","volume":"279","author":"Voss","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.spen.2019.01.004_bib0094","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1113\/JP274229","article-title":"Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy","volume":"595","author":"Pinniger","year":"2017","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/j.spen.2019.01.004_bib0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nmd.2011.02.012","article-title":"Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies","volume":"21","author":"Robb","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.spen.2019.01.004_bib0096","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1242\/dmm.009746","article-title":"Myotubular myopathy and the neuromuscular junction: A novel therapeutic approach from mouse models","volume":"5","author":"Dowling","year":"2012","journal-title":"Dis Models Mech"},{"key":"10.1016\/j.spen.2019.01.004_bib0097","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00109-013-0994-4","article-title":"Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy","volume":"91","author":"Gibbs","year":"2013","journal-title":"J Mol Med"},{"issue":"3","key":"10.1016\/j.spen.2019.01.004_bib0098","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00415-015-8015-x","article-title":"KLHL40-related nemaline myopathy with a sustained, positive response to treatment with acetylcholinesterase inhibitors","volume":"263","author":"Natera-de Benito","year":"2016","journal-title":"J Neurol:"},{"key":"10.1016\/j.spen.2019.01.004_bib0099","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-2004-821173","article-title":"Pilot trial of salbutamol in central core and multi-minicore diseases","volume":"35","author":"Messina","year":"2004","journal-title":"Neuropediatrics"},{"issue":"Suppl 3","key":"10.1016\/j.spen.2019.01.004_bib0100","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1007\/s10545-010-9085-7","article-title":"Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction","volume":"33","author":"Schreuder","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2019.01.004_bib0101","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.spen.2019.01.004_bib0102","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/156652312800840577","article-title":"Interference with myostatin\/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy","volume":"12","author":"Amthor","year":"2012","journal-title":"Curr Gene Ther"},{"issue":"16","key":"10.1016\/j.spen.2019.01.004_bib0103","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1093\/hmg\/ddv195","article-title":"Epigenetic changes as a common trigger of muscle weakness in congenital myopathies","volume":"24","author":"Rokach","year":"2015","journal-title":"Hum Mol Gent"},{"key":"10.1016\/j.spen.2019.01.004_bib0104","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1093\/emboj\/18.18.5099","article-title":"HDAC4 deacetylase associates with and represses the MEF2 transcription factor","volume":"18","author":"Miska","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.spen.2019.01.004_bib0105","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI71919","article-title":"Chemical chaperone ameliorates pathological protein aggregation in plectin-deficient muscle","volume":"124","author":"Winter","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.spen.2019.01.004_bib0106","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.2174\/1381612811319280006","article-title":"Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer s disease-like phenotype of a commonly used mouse model","volume":"19","author":"Cuadrado-Tejedor","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.spen.2019.01.004_bib0107","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1038\/ncomms14659","article-title":"A chemical chaperone improves muscle function in mice with a RyR1 mutation","volume":"8","author":"Lee","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.spen.2019.01.004_bib0108","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/0883073807309794","article-title":"Dietary L-tyrosine supplementation in nemaline myopathy","volume":"23","author":"Ryan","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2019.01.004_bib0109","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1093\/brain\/awr274","article-title":"Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy","volume":"134","author":"Nguyen","year":"2011","journal-title":"Brain J Neurol"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107190911930004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107190911930004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T21:41:31Z","timestamp":1565214091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107190911930004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":109,"alternative-id":["S107190911930004X"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2019.01.004","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Aspects in Congenital Myopathies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}